EU Novel Food Regulation 2015/2283: Supplement Ingredient Authorisation Deep-Dive

Article 3 of Regulation 2015/2283 defines novel food as food not used for human consumption to a significant degree within the Union before 15 May 1997. The Regulation enumerates ten novel-food categories including food with new or intentionally modified molecular structure, food from microorganisms/fungi/algae, food from materials of mineral origin, food from plants/parts of plants except where the food has a history of safe use, food from animals except where derived from animals with a history of safe food use, food from cell culture/tissue culture from animals/plants/microorganisms/fungi/algae, food resulting from a new production process altering nutritional value/metabolism/level of undesirable substances, food consisting of engineered nanomaterials, and food vitamins/minerals/other substances within scope of Directive 2002/46/EC where novel production process or nanomaterial form has been used. The 1997 cutoff anchors history-of-consumption assessment — ingredient suppliers compile dossier evidence (commercial sales records, trade data, scientific publications, market surveys) demonstrating pre-1997 EU food use to establish non-novel status, with EU Member State competent authority consultation under Article 4 to clarify status. The Novel Food Catalogue is the Commission's informal published reference of status determinations and is the practical starting point for any ingredient-status check.

Standard novel-food authorisation under Articles 10-12 requires submission to the European Commission with administrative dossier (applicant, product description, proposed use conditions and labelling), scientific dossier (identity and characterisation, production process, history of organism used as source, proposed use and use levels, anticipated intake and dietary exposure, ADME — absorption, distribution, metabolism and excretion — data, nutritional information, toxicological information including genotoxicity, sub-chronic and chronic toxicity, reproductive and developmental toxicity, allergenicity assessment, human studies as available). The Commission requests EFSA scientific opinion (typically 9-18 months including stop-clock for data requests). On positive EFSA opinion, the Commission drafts an implementing act with specific use conditions (matrix, maximum levels, target population restrictions, labelling requirements) and submits to Member State vote via Standing Committee. On adoption, the ingredient is added to the Union List of authorised novel foods. Total timeline from validated application to Union List publication is typically 18-30 months. Authorisation is generic unless data protection (Article 26, 5-year exclusivity for substantial newly-developed scientific evidence) is granted to the applicant.

Articles 14-20 establish an accelerated pathway for traditional food from third country — food that has a history of safe food use in a third country for at least 25 years as part of the customary diet of a significant number of people. Notification dossier includes food name and description, composition, production process, country of origin and history of use evidence (literature, ethnobotanical sources, trade and population data), proposed use conditions in the Union and proposed labelling. EFSA and Member State authorities have four months to raise reasoned safety objections. If no objection is raised, the food is authorised at proposed use conditions via Commission implementing act and added to the Union List. If objections are raised, the applicant may either withdraw and pursue standard authorisation or submit additional safety data for resolution. Traditional-food authorisation is generic without data protection. This pathway has enabled EU authorisation of ingredients with strong third-country history of use — baobab pulp, chia seeds at extended use, noni juice, certain insect species (yellow mealworm, migratory locust, house cricket, lesser mealworm), specific algal and fungal products. Total timeline is typically 12-18 months for objection-free notifications.

The Union List of authorised novel foods is maintained by Commission Implementing Regulation 2017/2470 and amended through implementing acts as new authorisations are granted. The List specifies for each authorised novel food the conditions of use (food category matrix and maximum level), specifications (identity, purity, microbiological and physicochemical), labelling requirements (designation as a novel food where applicable, allergen warnings, population restrictions) and any data protection scope and validity. Data protection under Article 26 (5-year exclusivity for substantial newly-developed scientific evidence underpinning the authorisation) grants the original applicant the exclusive right to market the novel food under the authorised conditions during the protection period — competitors may use the authorisation only after expiry or by submitting independent dossier. Use-condition extensions or variations require submission of variation dossier with EFSA re-evaluation. Authorisation revocation is possible on new safety evidence under Article 12. Post-market monitoring may be imposed by the Commission for specific authorisations with collection of consumption data, adverse-event reports or specific safety endpoints over defined period. Operational discipline includes per-ingredient Union List monitoring for amendments affecting authorised use conditions, data protection expiry tracking for competitive entry planning and post-market monitoring fulfilment.